Common use
Roflumilast, marketed under the brand name Daliresp, is a selective PDE4 inhibitor (phosphodiesterase-4 inhibitor) used as an anti-inflammatory treatment for severe chronic obstructive pulmonary disease (COPD) associated with chronic bronchitis. When you buy Roflumilast online, you are obtaining a targeted respiratory medication designed specifically for exacerbation prevention in patients with a history of frequent COPD flare-ups. Unlike bronchodilators that simply open the airways, roflumilast works at the cellular level by inhibiting the PDE4 enzyme, which reduces the inflammatory cascade in the lungs and airways. This mechanism helps decrease the frequency and severity of COPD exacerbations that can lead to hospitalization and progressive lung damage. This Daliresp generic is particularly beneficial for patients with severe COPD who continue to experience exacerbations despite using inhaled corticosteroids and long-acting bronchodilators. By targeting the underlying inflammation that drives chronic bronchitis and COPD progression, roflumilast provides an important additional layer of respiratory protection for patients managing this complex condition.

Dosage and direction
Take roflumilast orally once daily, with or without food, exactly as prescribed by your doctor. The standard recommended dose for adults is 500 mcg (0.5 mg) taken once per day. Swallow the tablet whole with a full glass of water — do not crush, chew, or split the tablet. It is best to take this PDE4 inhibitor at the same time each day to maintain consistent blood levels and maximize its effectiveness for exacerbation prevention. Some healthcare providers may recommend starting at a lower dose of 250 mcg daily for the first four weeks to help minimize initial gastrointestinal side effects before increasing to the full maintenance dose. Be patient with results, as roflumilast is a long-term COPD treatment that works gradually by reducing lung inflammation over weeks of consistent use. This medication is not a rescue inhaler and should not be used to relieve acute bronchospasm or sudden breathing difficulties.

Precautions
Before you buy roflumilast, inform your doctor about your complete medical history, particularly if you have liver disease, a history of depression, anxiety, suicidal thoughts, or other mental health conditions. This anti-inflammatory respiratory medication can cause neuropsychiatric side effects including mood changes, insomnia, and in rare cases, suicidal ideation, which require immediate medical attention. Weight loss is a common occurrence during roflumilast treatment, so patients who are already underweight should be monitored carefully. Regular medical follow-ups are recommended throughout therapy to assess treatment response, monitor body weight, and evaluate mental health status. Patients should also be aware that this COPD treatment does not replace bronchodilators or inhaled corticosteroids but is used alongside them as part of a comprehensive respiratory management plan.

Contraindications
Do not use roflumilast if you have moderate to severe liver impairment (Child-Pugh B or C classification), as the drug is extensively metabolized by the liver and impaired clearance can lead to dangerously elevated blood levels. This Daliresp generic is not intended for use during acute COPD attacks or asthma episodes — it is strictly a maintenance medication for exacerbation prevention. Roflumilast is contraindicated in individuals with known hypersensitivity to roflumilast or any of the tablet's excipients. The medication is not recommended during pregnancy or breastfeeding unless the potential benefit clearly outweighs the risks, as adequate human safety data are limited.

Possible side effect
Common side effects of this PDE4 inhibitor include diarrhea, nausea, reduced appetite, weight loss, headache, back pain, and insomnia. These gastrointestinal and neurological effects are most pronounced during the first few weeks of treatment and typically diminish as the body adjusts to the medication. Less common but more serious side effects may include significant mood changes, new or worsening depression, anxiety, panic attacks, or suicidal thoughts. If you experience any psychiatric symptoms while taking this respiratory medication, contact your healthcare provider immediately. Some patients may also experience abdominal pain, dizziness, or muscle cramps. Report any persistent or unusual symptoms to your doctor promptly.

Drug interaction
Roflumilast is metabolized by the cytochrome P450 system, primarily CYP3A4 and CYP1A2 enzymes, and may interact with medications that inhibit or induce these pathways. Strong CYP3A4 inhibitors such as ketoconazole, itraconazole, and ritonavir can significantly increase roflumilast blood levels and potentially amplify side effects. Conversely, strong CYP3A4 inducers like rifampin, phenobarbital, carbamazepine, and phenytoin can substantially reduce roflumilast effectiveness by accelerating its metabolism. Concurrent use with theophylline is not recommended, as it may increase the risk of adverse reactions. Always provide your doctor with a complete list of all prescription medications, over-the-counter drugs, and dietary supplements you are taking before starting this anti-inflammatory COPD treatment.

Missed dose
If you miss a dose of roflumilast, take it as soon as you remember on the same day. If it is nearly time for your next scheduled dose, skip the missed dose entirely and continue with your regular daily schedule. Do not take two doses at once or double up to compensate for a missed dose. Consistent daily use is important for maintaining the anti-inflammatory effect that provides exacerbation prevention in COPD patients.

Overdose
Symptoms of roflumilast overdose may include severe nausea, vomiting, diarrhea, headache, dizziness, palpitations, and significant mental or mood changes. In such cases, seek emergency medical assistance immediately. There is no specific antidote for this PDE4 inhibitor, so treatment is primarily supportive and symptom-based. Contact your local poison control center or emergency department if you suspect an overdose of this respiratory medication.

Storage
Store roflumilast (Daliresp generic) at controlled room temperature between 59-77°F (15-25°C), away from excessive heat, direct sunlight, and moisture. Keep the tablets in their original container or blister packaging and store them out of reach of children and pets. Do not use this COPD treatment medication past its printed expiration date. Dispose of unused tablets responsibly following local pharmaceutical disposal guidelines.

Disclaimer

We provide only general information about medications which does not cover all directions, possible drug integrations, or precautions. Information at the site cannot be used for self-treatment and self-diagnosis. Any specific instructions for a particular patient should be agreed with your health care adviser or doctor in charge of the case. We disclaim reliability of this information and mistakes it could contain. We are not responsible for any direct, indirect, special or other indirect damage as a result of any use of the information on this site and also for consequences of self-treatment.